Eldred Kary

Galectin Therapeutics Inc. · Director

Eldred Kary is listed in public filings as director. This Eldred Kary insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Eldred Kary's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Galectin Therapeutics Inc.GALT$810300 sharesBuyFeb 6, 2026$2.70--